Author: Bicheng Zhang; Xiaoyang Zhou; Chengliang Zhu; Fan Feng; Yanru Qiu; Jia Feng; Qingzhu Jia; Qibin Song; Bo Zhu; Jun Wang
Title: Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19 Document date: 2020_3_16
ID: 68193u0a_2
Snippet: However, the dynamic of anti-SARS-CoV-2 antibody upon virus infection and their relation to disease status and outcome remains to be determined. 5 Here, we evaluated antibody response within 35 days after symptom onset in laboratory-confirmed case with COVID-19 as one component of an overall exaggerated immune activation in severe SARS-CoV-2 infection, and developed an immune phenotyping based on late IgG response and NLR that could help determin.....
Document: However, the dynamic of anti-SARS-CoV-2 antibody upon virus infection and their relation to disease status and outcome remains to be determined. 5 Here, we evaluated antibody response within 35 days after symptom onset in laboratory-confirmed case with COVID-19 as one component of an overall exaggerated immune activation in severe SARS-CoV-2 infection, and developed an immune phenotyping based on late IgG response and NLR that could help determine disease severity and clinical outcome of COVID-19 patients.
Search related documents:
Co phrase search for related documents- anti sars and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- anti sars and IgG response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- anti sars and immune activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- anti sars and immune phenotyping: 1, 2, 3, 4
- anti sars and late IgG response: 1, 2, 3
- anti sars and NLR late IgG response: 1, 2
- anti sars and outcome status: 1, 2, 3, 4
- anti sars antibody and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- anti sars antibody and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- anti sars antibody and IgG response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- anti sars antibody and immune activation: 1, 2
- anti sars antibody and late IgG response: 1
- anti sars antibody and outcome status: 1, 2
- antibody response and disease severity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antibody response and immune activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antibody response and immune phenotyping: 1, 2
- antibody response and late IgG response: 1, 2
- antibody response and NLR late IgG response: 1, 2
- antibody response and outcome status: 1
Co phrase search for related documents, hyperlinks ordered by date